Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| BIOGEN INC. | 470 278 | déclaré | 03 juin 2009 | tx 106+338 345−960 220 |
| Syros Pharmaceuticals, Inc. | 11 000 | déclaré | 11 juin 2019 | tx 13+332 666−1 000 000 |
| ALNYLAM PHARMACEUTICALS, INC. | 9 000 | déclaré | 01 juil. 2019 | tx 76+1 388 328−1 292 061 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 01 juil. 2019 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 9 000 | 0.00 USD | deriv |
| 11 juin 2019 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 11 000 | 0.00 USD | deriv |
| 15 avr. 2019 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 400 | 89.97 USD | |
| 15 avr. 2019 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 2 200 | 89.03 USD | |
| 15 avr. 2019 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 22.09 USD | |
| 15 avr. 2019 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 600 | 91.40 USD | |
| 15 avr. 2019 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 11 800 | 87.86 USD | |
| 15 avr. 2019 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |
| 20 juin 2018 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 9 000 | 0.00 USD | deriv |
| 14 juin 2018 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 11 000 | 0.00 USD | deriv |
| 13 mars 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 21.35 USD | |
| 13 mars 2018 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 149.00 USD | |
| 13 mars 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |
| 09 mars 2018 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 129.00 USD | |
| 09 mars 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 27.28 USD | |
| 09 mars 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |
| 08 juin 2017 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 11 000 | 0.00 USD | deriv |
| 02 juin 2017 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 11 250 | 0.00 USD | deriv |
| 01 févr. 2017 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 4 829 | 40.16 USD | |
| 01 févr. 2017 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 25 000 | 31.29 USD | |
| 01 févr. 2017 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 20 171 | 39.72 USD | |
| 01 févr. 2017 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 25 000 | 0.00 USD | deriv |
| 25 janv. 2017 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 31.39 USD | |
| 25 janv. 2017 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 37.95 USD | |
| 25 janv. 2017 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |